Vivo opportunity reports 6.2% passive stake in avadel pharma as of feb 25

Vivo opportunity llc reports 6.2% passive stake in avadel pharmaceuticals plc as of february 25, 2020 - sec filing.
AVDL Ratings Summary
AVDL Quant Ranking